Daewoong Pharmaceutical’s “‘Hoystar tablet’ could not meet the main evaluation variable in phase 2a clinical trial for corona treatment”
Daewoong Pharmaceutical’s Hoy Star tablet phase 2a main evaluation variable not satisfied…2b/3 phase progress
